mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
6e-08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
6e-06 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
1e-05 |